P2X7 receptor appears to hinder tumor growth by promoting DC/tumor cell interaction, cytokine release, chemotaxis, and infiltration of immune cells in the TME (Adinolfi et al., 2015; Di Virgilio, 2016). Here, P2RX7 is linked to neoplasm.